Skip to content
10-Q

Quarterly Report

HCA Healthcare, Inc. HCA

0001193125-25-258667

← back to feed
Filed
Oct 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 27, 2025 228.19M sh
Shares Diluted Q3 2025 · Sep 30, 2025 236.18M sh
Shares Diluted Q3 2025 · Sep 30, 2025 242.46M sh
Shares Diluted Q3 2025 · Sep 30, 2024 259.92M sh
Shares Diluted Q3 2025 · Sep 30, 2024 263.99M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $7.51B
Stock Repurchased Q3 2025 · Sep 30, 2024 $4.34B
Capex Q3 2025 · Sep 30, 2025 $3.46B
Capex Q3 2025 · Sep 30, 2024 $3.59B
Operating Cash Flow Q3 2025 · Sep 30, 2025 $10.28B
Operating Cash Flow Q3 2025 · Sep 30, 2024 $7.96B
Long Term Debt Q3 2025 · Sep 30, 2025 $38.4B
Long Term Debt Q3 2025 · Dec 31, 2024 $38.33B
Short Term Debt Q3 2025 · Sep 30, 2025 $6.11B
Short Term Debt Q3 2025 · Dec 31, 2024 $4.7B
Cash And Equivalents Q3 2025 · Sep 30, 2025 $997M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $1.93B
Stockholders Equity Q3 2025 · Sep 30, 2025 −$5.34B
Stockholders Equity Q3 2025 · Dec 31, 2024 −$2.5B
Current Liabilities Q3 2025 · Sep 30, 2025 $17.9B
Current Liabilities Q3 2025 · Dec 31, 2024 $15.18B
Current Assets Q3 2025 · Sep 30, 2025 $15.29B
Current Assets Q3 2025 · Dec 31, 2024 $16.41B
Total Assets Q3 2025 · Sep 30, 2025 $59.75B
Total Assets Q3 2025 · Dec 31, 2024 $59.51B
Eps Diluted Q3 2025 · Sep 30, 2025 $6.96
Eps Diluted Q3 2025 · Sep 30, 2025 $20.23
Eps Diluted Q3 2025 · Sep 30, 2024 $4.88
Eps Diluted Q3 2025 · Sep 30, 2024 $16.37
Eps Basic Q3 2025 · Sep 30, 2025 $7.05
Eps Basic Q3 2025 · Sep 30, 2025 $20.47
Eps Basic Q3 2025 · Sep 30, 2024 $4.94
Eps Basic Q3 2025 · Sep 30, 2024 $16.57
Sga Expense Q3 2025 · Sep 30, 2025 $139M
Sga Expense Q3 2025 · Sep 30, 2025 $395M
Sga Expense Q3 2025 · Sep 30, 2024 $111M
Sga Expense Q3 2025 · Sep 30, 2024 $301M
Net Income Q3 2025 · Sep 30, 2025 $1.64B
Net Income Q3 2025 · Sep 30, 2025 $4.91B
Net Income Q3 2025 · Sep 30, 2024 $1.27B
Net Income Q3 2025 · Sep 30, 2024 $4.32B
Revenue Q3 2025 · Sep 30, 2025 $19.16B
Revenue Q3 2025 · Sep 30, 2025 $56.09B
Revenue Q3 2025 · Sep 30, 2024 $17.49B
Revenue Q3 2025 · Sep 30, 2024 $52.32B